Benicar HCT Related Published Studies
Well-designed clinical trials related to Benicar HCT (Olmesartan / Hydrochlorothiazide)
Olmesartan/amlodipine vs olmesartan/hydrochlorothiazide in hypertensive patients with metabolic syndrome: the OLAS study. [2011.06]
Effect of delapril/manidipine vs olmesartan/ hydrochlorothiazide combination on insulin sensitivity and fibrinogen in obese hypertensive patients. [2008]
Evaluation of antihypertensive therapy with the combination of olmesartan medoxomil and hydrochlorothiazide. [2004.03]
A review of olmesartan medoxomil monotherapy: antihypertensive efficacy similar to that of other angiotensin II receptor blocker/hydrochlorothiazide combinations? [2002.11]
Well-designed clinical trials possibly related to Benicar HCT (Olmesartan / Hydrochlorothiazide)
Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation. [2004.08.31]
Other research related to Benicar HCT (Olmesartan / Hydrochlorothiazide)
Olmesartan medoxomil combined with hydrochlorothiazide improves 24-hour blood pressure control in moderate-to-severe hypertension. [2011.11.25]
Ratio spectra derivative and zero-crossing difference spectrophotometric determination of olmesartan medoxomil and hydrochlorothiazide in combined pharmaceutical dosage form. [2009]
Effects of Manidipine/Delapril versus Olmesartan/Hydrochlorothiazide Combination Therapy in Elderly Hypertensive Patients with Type 2 Diabetes Mellitus. [2008.01]
Olmesartan medoxomil: a review of its use in the management of hypertension. [2008]
Clinical efficacy and safety of olmesartan/hydrochlorothiazide combination therapy in patients with essential hypertension. [2008]
Adding hydrochlorothiazide to olmesartan dose dependently improves 24-h blood pressure and response rates in mild-to-moderate hypertension. [2005.11]
Use of an olmesartan medoxomil-based treatment algorithm for hypertension control. [2004.04]
Antihypertensive efficacy of olmesartan medoxomil alone and in combination with hydrochlorothiazide. [2004.03]
Renal effects of 26-week administration of olmesartan medoxomil/hydrochlorothiazide in rats. [2004.02]
Olmesartan compared with other angiotensin II receptor antagonists: head-to-head trials. [2004]
Clinical efficacy and tolerability of olmesartan. [2004]
Antihypertensive efficacy of olmesartan compared with other antihypertensive drugs. [2002.05]
Relative efficacy of an angiotensin II antagonist compared with other antihypertensive agents. Olmesartan medoxomil versus antihypertensives. [2001.06]
Other possibly related research studies
Enhanced intrarenal angiotensinogen contributes to early renal injury in spontaneously hypertensive rats. [2005.07]
Gateways to clinical trials. [2005.03]
Gateways to clinical trials. [2004.09]
Antihypertensive efficacy of angiotensin receptor blockers in combination with hydrochlorothiazide: a review of the factorial-design studies. [2004.10]
Irbesartan: a review of its use in hypertension and in the management of diabetic nephropathy. [2004]
Differential effects between a calcium channel blocker and a diuretic when used in combination with angiotensin II receptor blocker on central aortic pressure in hypertensive patients. [2009.10]
|
